Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Lists including Shyam
Investments
Work Experience
2020
Managing Director
2020
At Fine Structure Ventures, an F-Prime Capital Fund (affiliated with FMR LLC, the parent company of Fidelity Investments), we back deep scientific and technical innovators raising Series-A/B/C rounds. Our VC fund is focused on revolutionary paradigms in next generation computing, energy/climate tech, biology, materials, and aerospace. Current investments include Commonwealth Fusion Systems (nuclear fusion), Mainspring Energy (on-site clean power generation), and Boston Metal (electrolytic extraction of steel).
2020
Board Observer
2024
Member Board Of Directors
2020 - 2024
2024
Managing Director - Fine Structure Ventures
2024
As of July 1, 2024, Fine Structure Ventures is an F-Prime fund.
2020
Member Board Of Directors
2020
2021
Board Observer / Investor
2021
Developer of a cell-free biomanufacturing technology and platform designed to create complex and high-value ingredients. The company's platform harnesses natural enzyme approaches to overcome cell limitations and provide a sustainable, low-cost, and consistent supply of natural ingredients, enabling clients to have access to sustainably produced ingredients.
2021
Member Board Of Directors
2021
2022
Member Board of Directors
2022
The current generation of AI hardware (TPU, GPU, CPU) is not optimized for edge AI especially as the complexity of tasks and memory requirements increases. Femtosense has developed a 2D array of tightly coupled digital compute and memory blocks that exploit network sparsity coupled with an algorithm that trains networks to expose their underlying sparsity while maintaining performance. This coupled hardware and algorithm approach allows Femtosense to deliver the AI performance of large models in constrained edge platforms.
2021
Member Board Of Directors
2021
2024
Member Board of Directors
2024
Radian is building a next-generation spaceplane planned to be the world's first single-stage-to-orbit, truly reusable space vehicle operating in Low Earth orbit.
2004
Member Board of Directors
2004
At Constructive Bio, they rewrite the genome to build the biomolecules of the future. Their unique technology transforms living cells into biofactories, producing sustainable new materials and therapeutics. With complete control over the genetic sequence and code, they are exploring chemical space that natural biology has not previously accessed. Learn more at constructive.bio.